Effects of mood stabilizers on brain reward processes in rats: Studies using the intracranial self-stimulation paradigm

European Neuropsychopharmacology

Volumn 19, Issue 3, 2009, Pages 205-214

  Mavrikaki, Maria ^a   Nomikos, George G ^b   Panagis, George ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Animal model; Brain stimulation reward; ; d Amphetamine; ; Mood stabilizers; ; Reinforcement;

Indexed keywords

DEXAMPHETAMINE; LITHIUM CHLORIDE; MOOD STABILIZER; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; DOSE RESPONSE; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG COMBINATIONS; LITHIUM CHLORIDE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SELF ADMINISTRATION; VALPROIC ACID;

EID: 58949100292     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.11.002     Document Type: Article

References (77)

1. Abler B., Greenhouse I., Ongur D., Walter H., and Heckers S. Abnormal reward system activation in mania. Neuropsychopharmacology 33 (2008) 2217-2227
2. Altamura A.C. Bipolar spectrum and drug addiction. J. Affect. Disord. 99 (2007) 285
3. Aly M.I., and Abdel-Latif A.A. Studies on distribution and metabolism of valproate in rat brain, liver, and kidney. Neurochem. Res. 5 (1980) 1231-1242
4. Anand A., Verhoeff P., Seneca N., Zoghbi S.S., Seibyl J.P., Charney D.S., and Innis R.B. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am. J. Psychiatry 157 (2000) 1108-1114
5. Angrist B., and Gershon S. Variable attenuation of amphetamine effects by lithium. Am. J. Psychiatry 136 (1979) 806-810
6. Angrist B., Corwin J., Bartlik B., and Cooper T. Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biol. Psychiatry 22 (1987) 1357-1368
7. Antoniou K., Papathanasiou G., Panagis G., Nomikos G.G., Hyphantis T., and Papadopoulou-Daifoti Z. Individual responses to novelty predict qualitative differences in d-amphetamine-induced open field but not reward-related behaviors in rats. Neuroscience 123 (2004) 613-623
8. Baldessarini R.J. Treatment research in bipolar disorder: issues and recommendations. CNS. Drugs. 16 (2002) 721-729
9. Bell E.C., Willson M.C., Wilman A.H., Dave S., Asghar S.J., and Silverstone P.H. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. Hum. Psychopharmacol. 20 (2005) 87-96
10. Bell E.C., Willson M.C., Wilman A.H., Dave S., and Silverstone P.H. Differential effects of chronic lithium and valproate on brain activation in healthy volunteers. Hum. Psychopharmacol. 20 (2005) 415-424
11. Belmaker R.H. Bipolar disorder. N. Engl. J. Med. 351 (2004) 476-486
12. Berggren U., Tallstedt L., Ahlenius S., and Engel J. The effect of lithium on amphetamine-induced locomotor stimulation. Psychopharmacology (Berl) 59 (1978) 41-45
13. Bespalov A., Lebedev A., Panchenko G., and Zvartau E. Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats. Eur. Neuropsychopharmacol. 9 (1999) 377-383
14. Borison R.L., Sabelli H.C., Maple P.J., Havdala H.S., and Diamond B.I. Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamine. Psychopharmacology (Berl) 59 (1978) 259-262
15. Bossert J.M., and Franklin K.B. Reinforcing versus anticonvulsant drugs: effects on intracranial self-stimulation rate-frequency M50 indices. Behav. Brain Res. 144 (2003) 243-247
16. Bowden C.L. Predictors of response to divalproex and lithium. J. Clin. Psychiatry 56 Suppl 3 (1995) 25-30
17. Brauer L.H., and de Wit H. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol. Psychiatry 39 (1996) 26-32
18. Burgess S., Geddes J., Hawton K., Townsend E., Jamison K., and Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst. Rev. (2001) CD003013
19. Campbell K.A., Evans G., and Gallistel C.R. A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation. Physiol. Behav. 35 (1985) 395-403
20. Carlezon Jr. W.A., and Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2 (2007) 2987-2995
21. Carr K.D., Yamamoto N., Omura M., Cabeza de Vaca S., and Krahne L. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats. Psychopharmacology (Berl) 163 (2002) 76-84
22. Cassens G.P., and Mills A.W. Lithium and amphetamine: opposite effects on threshold of intracranial reinforcement. Psychopharmacologia 30 (1973) 283-290
23. Cerullo M.A., and Strakowski S.M. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst. Abuse Treat. Prev. Policy 2 (2007) 29
24. Coulombe D., and Miliaressis E. Fitting intracranial self-stimulation data with growth models. Behav. Neurosci. 101 (1987) 209-214
25. Cox C., Harrison-Read P.E., Steinberg H., and Tomkiewicz M. Lithium attenuates drug-induced hyperactivity in rats. Nature 232 (1971) 336-338
26. Depoortere R., Perrault G., and Sanger D.J. Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol. Psychopharmacology (Berl) 142 (1999) 221-229
27. Edmonds D.E., and Gallistel C.R. Parametric analysis of brain stimulation reward in the rat: III. effect of performance variables on the reward summation function. J. Comp. Physiol. Psychol. 87 (1974) 876-883
28. Einat H., Manji H.K., and Belmaker R.H. New approaches to modeling bipolar disorder. Psychopharmacol. Bull. 37 (2003) 47-63
29. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behav. Genet. 37 (2007) 244-255
30. Flemenbaum A. Does lithium block the effects of amphetamine? A report of three cases. Am. J. Psychiatry 131 (1974) 820-821
31. Fountoulakis K.N., Vieta E., Siamouli M., Valenti M., Magiria S., Oral T., Fresno D., Giannakopoulos P., and Kaprinis G.S. Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Ann. Gen. Psychiatry 6 (2007) 27
32. Frank R.A., Tsibulsky V., Grocki S., Dashevsky B., Kehne J.H., Schmidt C.J., and Sorensen S.M. Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward. Pharmacol. Biochem. Behav. 52 (1995) 799-804
33. Frost R.E., and Messiha F.S. Clinical uses of lithium salts. Brain Res. Bull. 11 (1983) 219-231
34. Gallistel C.R., and Karras D. Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacol. Biochem. Behav. 20 (1984) 73-77
35. Gallistel C.R., and Freyd G. Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation. Pharmacol. Biochem. Behav. 26 (1987) 731-741
36. Geddes J.R., Burgess S., Hawton K., Jamison K., and Goodwin G.M. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am. J. Psychiatry. 161 (2004) 217-222
37. Goodwin F.K., and Jamison K.R. Manic-depressive Illness: Bipolar Disorders and Recurrent Depression, Vol. (2007), Oxford University Press, Oxford
38. Gould T.J., Keith R.A., and Bhat R.V. Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behav. Brain Res. 118 (2001) 95-105
39. Gyulai L., Bowden C.L., McElroy S.L., Calabrese J.R., Petty F., Swann A.C., Chou J.C., Wassef A., Risch C.S., Hirschfeld R.M., Nemeroff C.B., Keck Jr. P.E., Evans D.L., and Wozniak P.J. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 28 (2003) 1374-1382
40. Ichikawa J., and Meltzer H.Y. Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1A receptor activation. Eur. J. Pharmacol. 380 (1999) R1-3
41. Ichikawa J., Chung Y.C., Dai J., and Meltzer H.Y. Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release. Brain. Res. 1052 (2005) 56-62
42. Ichikawa J., Dai J., and Meltzer H.Y. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism. Brain Res. 1049 (2005) 182-190
43. Jacobs D., and Silverstone T. Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychol. Med. 16 (1986) 323-329
44. Kahn D.A., Sachs G.S., Printz D.J., Carpenter D., Docherty J.P., and Ross R. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines. J. Psychiatr. Pract. 6 (2000) 197-211
45. Kasper S. Issues in the treatment of bipolar disorder. Eur. Neuropsychopharmacol. 13 Suppl 2 (2003) S37-42
46. Kornetsky C. Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA. Res. Monogr. 62 (1985) 30-50
47. Kornetsky C., and Esposito R.U. Euphorigenic drugs: effects on the reward pathways of the brain. Fed. Proc. 38 (1979) 2473-2476
48. Liebman J.M. Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci. Biobehav. Rev. 7 (1983) 45-72
49. Lin D., Bruijnzeel A.W., Schmidt P., and Markou A. Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine. Neuroscience 114 (2002) 925-933
50. Maremmani I., Pacini M., Perugi G., Deltito J., and Akiskal H. Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model. J. Affect. Disord. 106 (2008) 55-61
51. Markou A., and Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4 (1991) 17-26
52. Markou A., and Koob G.F. Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol. Behav. 51 (1992) 111-119
53. McIntyre R.S., McElroy S.L., Konarski J.Z., Soczynska J.K., Bottas A., Castel S., Wilkins K., and Kennedy S.H. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J. Clin. Psychiatry 68 (2007) 1352-1357
54. Miliaressis E., Rompre P.P., Laviolette P., Philippe L., and Coulombe D. The curve-shift paradigm in self-stimulation. Physiol. Behav. 37 (1986) 85-91
55. Moller H.J., and Nasrallah H.A. Treatment of bipolar disorder. J. Clin. Psychiatry 64 Suppl 6 (2003) 9-17 discussion 28
56. Morrison Jr. J.M., Pritchard H.D., Braude M.C., and D'Aguanno W. Plasma and brain lithium levels after lithium carbonate and lithium chloride administration by different routes in rats. Proc. Soc. Exp. Biol. Med. 137 (1971) 889-892
57. Olds J., and Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47 (1954) 419-427
58. Panagis G., and Spyraki C. Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation. Psychopharmacology (Berl) 123 (1996) 280-288
59. Paterson N.E., Myers C., and Markou A. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) 152 (2000) 440-446
60. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates, sixth ed. (2007), Elsevier, Amsterdam
61. Reischies F.M., Hartikainen J., and Berghofer A. Initial lithium and valproate combination therapy in acute mania. Neuropsychobiology 46 Suppl 1 (2002) 22-27
62. Roybal K., Theobold D., Graham A., DiNieri J.A., Russo S.J., Krishnan V., Chakravarty S., Peevey J., Oehrlein N., Birnbaum S., Vitaterna M.H., Orsulak P., Takahashi J.S., Nestler E.J., Carlezon Jr. W.A., and McClung C.A. Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6406-6411
63. Sharma V., Persad E., Mazmanian D., and Karunaratne K. Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can. J. Psychiatry 38 (1993) 137-139
64. Silverstone P.H., Pukhovsky A., and Rotzinger S. Lithium does not attenuate the effects of D-amphetamine in healthy volunteers. Psychiatry Res. 79 (1998) 219-226
65. Slattery D.A., Markou A., and Cryan J.F. Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) 190 (2007) 555-568
66. Solomon D.A., Ryan C.E., Keitner G.I., Miller I.W., Shea M.T., Kazim A., and Keller M.B. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J. Clin. Psychiatry 58 (1997) 95-99
67. Strakowski S.M., and Sax K.W. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Biol. Psychiatry 44 (1998) 1171-1177
68. Swann A.C., Bowden C.L., Morris D., Calabrese J.R., Petty F., Small J., Dilsaver S.C., and Davis J.M. Depression during mania. Treatment response to lithium or divalproex. Arch. Gen. Psychiatry 54 (1997) 37-42
69. Tomasiewicz H.C., Mague S.D., Cohen B.M., and Carlezon Jr. W.A. Behavioral effects of short-term administration of lithium and valproic acid in rats. Brain Res. 1093 (2006) 83-94
70. Van Kammen D.P., and Murphy D.L. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44 (1975) 215-224
71. Van Ree J.M., and Otte A.P. Effects of (Des-Tyr1)-gamma-endorphin and alpha-endorphin as compared to haloperidol and amphetamine on nucleus accumbens self-stimulation. Neuropharmacology 19 (1980) 429-434
72. Vlachou S., Nomikos G.G., and Panagis G. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) 188 (2006) 293-305
73. Willson M.C., Bell E.C., Dave S., Asghar S.J., McGrath B.M., and Silverstone P.H. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. Eur. Neuropsychopharmacol. 15 (2005) 633-639
74. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19 (1996) 319-340
75. Wise R.A., and Munn E. Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion. Behav. Brain Res. 55 (1993) 195-201
76. Wise R.A., and Munn E. Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology (Berl) 117 (1995) 130-136
77. Zacny J.P., Bodker B.K., and de Wit H. Effects of setting on the subjective and behavioral effects of d-amphetamine in humans. Addict. Behav. 17 (1992) 27-33